Journal article · 2005 · Open access

Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis

Massimo Claudio Fantini, C Becker, I Tubbe, A Nikolaev, H A Lehr, P Galle, M F Neurath

Gut, 55(5), 671–680 · Published 15 September 2005 · DOI 10.1136/gut.2005.072801

Open full textView at the publisherCite this paper

In brief

“Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis” is a 2005 journal article by Massimo Claudio Fantini and 6 co-authors, published in Gut. OpenAlex counts 283 citations as of 18 November 2026, which puts it in the top 7% of works published in 2005 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
283
Most cited in
2017 (17)
Field-weighted impact
8.08
References
39
Authors
7

Abstract

BACKGROUND AND AIMS: The imbalance between effector and regulatory T cells plays a central role in the pathogenesis of inflammatory bowel diseases. In addition to the thymus, CD4+CD25+ regulatory T cells can be induced in the periphery from a population of CD25- T cells by treatment with transforming growth factor beta (TGF-beta). Here, we analysed the in vivo function of TGF-beta induced regulatory T (Ti-Treg) cells in experimental colitis. METHODS: Ti-Treg cells were generated in cell culture in the presence or absence of TGF-beta and tested for their regulatory potential in experimental colitis using the CD4+CD62L+ T cell transfer model. RESULTS: Ti-Treg cells significantly suppressed Th1 mediated colitis on CD4+CD62L+ T cell transfer in vivo, as shown by high resolution endoscopy, histology, immunohistochemistry, and cytokine analysis. Further analysis of in vivo and in vitro expanded Ti-Treg cells showed that exogenous interleukin 2 (IL-2) was crucial for survival and expansion of these cells. CONCLUSION: Our data suggest that regulatory Ti-Treg cells expand by TGF-beta and exogenous IL-2 derived from effector T cells at the site of inflammation. In addition to Tr1 and thymic CD4+CD25+ T cells, peripheral Ti-Treg cells emerge as a class of regulatory T cells with therapeutic potential in T cell mediated chronic intestinal inflammation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Fantini, M. C., Becker, C., Tubbe, I., Nikolaev, A., Lehr, H. A., Galle, P., & Neurath, M. F. (2005). Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut, 55(5), 671–680. https://doi.org/10.1136/gut.2005.072801

MLA 9

Fantini, Massimo Claudio, et al. “Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.” Gut, vol. 55, no. 5, 2005, pp. 671–680. https://doi.org/10.1136/gut.2005.072801.

Chicago

Fantini, Massimo Claudio, C Becker, I Tubbe, A Nikolaev, H A Lehr, P Galle, and M F Neurath. 2005. “Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.” Gut 55 (5): 671–680. https://doi.org/10.1136/gut.2005.072801.

Harvard

Fantini, M. C. et al. (2005) ‘Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis’, Gut, 55(5), pp. 671–680. doi:10.1136/gut.2005.072801.

IEEE

M. C. Fantini et al., “Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis,” Gut, vol. 55, no. 5, pp. 671–680, 2005, doi: 10.1136/gut.2005.072801.

BibTeX

@article{fantini2005transforming,
  title     = {{Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis}},
  author    = {Fantini, Massimo Claudio and Becker, C and Tubbe, I and Nikolaev, A and Lehr, H A and Galle, P and Neurath, M F},
  journal   = {Gut},
  year      = {2005},
  volume    = {55},
  number    = {5},
  pages     = {671--680},
  doi       = {10.1136/gut.2005.072801},
  url       = {https://doi.org/10.1136/gut.2005.072801}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171717
201899
20191313
20201111
202166
20221313
202322
202477
202533
202666

Its field-weighted citation impact is 8.08: it has been cited 8.08 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology

  • Foxp3
  • experimental colitis
  • interleukin-2
  • CD4+CD25+ T cells
  • Tr1 cells
  • inflammatory bowel disease
  • chronic intestinal inflammation

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Fantini, M. C., Becker, C., Tubbe, I., Nikolaev, A., Lehr, H. A., Galle, P., & Neurath, M. F. (2005). Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut, 55(5), 671–680. https://doi.org/10.1136/gut.2005.072801

How many times has this paper been cited?

283 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Massimo Claudio Fantini, C Becker, I Tubbe, A Nikolaev, H A Lehr, P Galle, M F Neurath.

What is the DOI of this paper?

10.1136/gut.2005.072801, permanently at https://doi.org/10.1136/gut.2005.072801. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.